Press release
Gemigliptin Market Growth: Anticipated to Exceed USD 2.65 Billion by 2031.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And Industry Analysis 2031"The global Gemigliptin Market is estimated to reach over USD 2.65 billion by 2031, exhibiting a CAGR of 5.5% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2031
Gemigliptin is an oral diabetes medicine that belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It is used to treat type 2 diabetes, a chronic metabolic condition marked by insulin resistance and high blood sugar levels. Gemigliptin works by inhibiting the enzyme DPP-4, which is in charge of the breakdown of incretin hormones, which regulate blood glucose levels.
Gemigliptin enhances the levels of these hormones by blocking DPP-4, resulting in improved insulin secretion and decreased glucose synthesis by the liver. Due the rising incidence of diabetes worldwide and the increasing acceptance of efficient oral antidiabetic medications, the global Gemigliptin market has been steadily growing. Pharmaceutical companies continue investing in R&D to improve existing pharmaceuticals and discover novel treatments. This continuous innovation could lead to the release of newer and more advanced DPP-4 inhibitors, thereby growing the market. Gemigliptin is becoming more popular as a safer and more convenient diabetes treatment choice.
List of Prominent Players in the Gemigliptin Market:
• LG Chem
• Hanmi Pharmaceutical Co., Ltd.
• Boryung Pharmaceutical Co., Ltd.
• Novartis AG
• EirGenix, Inc.
• Biocon Limited
• G.L. Pharma GmbH
• Daewoong Pharmaceutical Co., Ltd.
• Sandoz International GmbH
• Boryung Pharmaceutical Co., Ltd.
• VHB Life Sciences Limited
• HanAll Biopharma
• Taiba Healthcare
• Huons Co., Ltd.
• Dong-A ST Co., Ltd
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
Diabetes is becoming more common worldwide at an alarming rate, affecting millions of people. Diabetes is becoming a significant public health concern, and there is an increasing demand for effective and safe antidiabetic medications like Gemigliptin to control the condition and improve patient outcomes. Furthermore, oral antidiabetic drugs are gradually replacing insulin injections due to their comfort and ease of administration. Gemigliptin is an oral antidiabetic medicine favored by patients who are not insulin-dependent, contributing to its market growth.
Challenges:
Gemigliptin faces significant competition from other types of diabetes drugs, such as metformin, sulfonylureas, and SGLT-2 inhibitors. Established pharmaceuticals with a lengthy history of usage and proven performance may hinder the market penetration of newer therapies like Gemigliptin. Patents on Gemigliptin and other DPP-4 inhibitors may expire, allowing generic copies to enter the market. This can lead to pricing challenges and limited revenue possibilities for branded Gemigliptin medicines. In addition, As with any medicine, safety issues might influence patient and physician opinions of Gemigliptin. Although the safety profile of Gemigliptin is generally well-established, continued monitoring and any safety alerts may limit its uptake and use.
Regional Trends:
The North America Gemigliptin Market is expected to report a major market share and is projected to grow at a high CAGR shortly. Diabetes, particularly type 2 diabetes, is a significant driver of the Gemigliptin market in North America. Diabetes has become more prevalent in the region due to factors such as sedentary lifestyles, bad diets, and obesity. Because of North America's well-developed healthcare infrastructure, drugs such as Gemigliptin are widely available. Healthcare providers have the resources necessary to diagnose, treat, and control diabetes properly. Diabetes prevalence, particularly type 2 diabetes, has risen dramatically in Asia. Changes have aided this rise in lifestyle, urbanization, and food preferences. The Asia Pacific area has a sizable generics market, and the advent of generic versions of Gemigliptin or other DPP-4 inhibitors could have an impact on market dynamics.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2031
Recent Developments:
• In March 2023, Sanofi introduced a new fixed-dose combination medication, including gemigliptin and saxagliptin (Jentadueto XR), in the United States. This medicine is indicated for treating individuals with type 2 diabetes mellitus who are not effectively controlled with diet and exercise alone or with other diabetes drugs.
Segmentation of Gemigliptin Market-
By Type of Drug-
• Gemigliptin Monotherapy
• Gemigliptin Combination Therapy)
By Dosage Form-
• Gemigliptin Tablets
• Gemigliptin Injectable
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End-User-
• Hospitals
• Clinics and Outpatient Facilities
• Homecare Settings
By Application-
• Type 2 diabetes
• Prediabetes
By Patient Demographics-
• Adult Population
• Geriatric Population
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2031
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gemigliptin Market Growth: Anticipated to Exceed USD 2.65 Billion by 2031. here
News-ID: 3795121 • Views: …
More Releases from Insightace Analytic Pvt Ltd.

Surface Treatment Chemicals Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Surface Treatment Chemicals Market Size, Share & Trends Analysis Report By Chemical Type (Cleaners, Plating Chemicals, Corrosion Protection Chemicals (Conversion Coatings, Coil Coatings)), Base Material (Metals, Plastics, And Others), By End Users Industry (Automotive, Construction, Aerospace, Electrical And Electronics, Coil Industry, Packaging Industry, And Others), By Treatment Method (Electroplating, Chemical Treatment, Thermal Spraying, Hot Dipping)Market…

Hormone-Responsive Skincare Market Shaping the Future of Women's Health and Targ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Hormone-Responsive Skincare Market"- By Life Stage (Puberty / Teen, Menstrual Cycle Syncing, Pregnancy & Postpartum, Menopause), By Product Type (Face care, Body care, Scalp & hair-adjacent, Sun care, Exfoliants), By Functional Concern (Acne/oil control, Sensitivity/redness/barrier repair, Dryness/itch/TEWL, Hyperpigmentation/melasma, Elasticity/firmness, stretch marks, Hot-flash/cooling relief, Intimate area comfort), By Channel (Online, Offline), and Global Forecasts, 2025-2034 And Segment…

Surface Guided Radiation Therapy (SGRT) Devices Market Revenue Report with Forec …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Surface Guided Radiation Therapy (SGRT) Devices Market Size, Share & Trends Analysis Report By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others)- Market Outlook And Industry Analysis 2034"
The global surface-guided radiation therapy (SGRT) devices market…

Sulfasalazine Market Exclusive Trends Analysis with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sulfasalazine Market- (By Product Type (Generic Sulfasalazine, Branded Sulfasalazine), By Application (Rheumatoid Arthritis, Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), By Patient Demographics (Adults, Pediatrics), By Disease Severity (Mild, Moderate, Severe), By Prescription Type (Over-the-Counter (OTC) with medical supervision, Prescription-only), By End-user (Hospitals, Clinics,…
More Releases for Gemigliptin
Gemigliptin Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And…
Gemigliptin Market Revenue Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And…
Gemigliptin Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And…
Gemigliptin Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And…
Gemigliptin Market Research Report 2023 | InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User (Hospitals, Clinics and Outpatient Facilities, & Homecare Settings), By Patient Demographics (Adultand Geriatric), Region, Market Outlook And…
Global Gemigliptin Market Size,Share,Development Overview,2023-2028|Sanofi, LG C …
Los Angeles, United States, - The report on the global Glass Bottle for Vaccine Use market is comprehensively prepared with a main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Glass Bottle for Vaccine Use Market. It offers a detailed analysis of…